Nationwide Fund Advisors Bio Techne Corp Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$121.17 - $134.75 $28.3 Million - $31.5 Million	-233,752 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$113.59 - $123.78 $533,077 - $580,899	4,693 Added 2.05%	233,752 $28.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	229,059	229,059 $26.9 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.